Abstract:
Refractive error is common, and when uncorrected is a significant disease burden worldwide with 98 million people visually impaired and five million people blind from refractive error alone. Refractive error can be corrected by spectacles, contact lenses or laser refractive surgery, with the latter becoming an increasingly popular treatment. The outcome of laser refractive surgery is assessed by clinical measures and patient reported outcomes, most importantly quality of life (QOL). A number of questionnaires exist for the measurement of quality of life after refractive surgery but these vary in validity. A refractive error related quality of life instrument should include a breadth of content areas e.g., well being, convenience and concerns, not just functioning or satisfaction. Rasch analysis has been used in the development of The Quality of Life Impact of Refractive Correction (QIRC) questionnaire which facilitated optimization of question inclusion, unidimensionality and valid linear scoring. The QIRC questionnaire, and others, readily demonstrates the benefits of refractive surgery. However, QIRC is also sensitive to the negative impacts of surgical complications, providing a global assessment of QOL outcome. The Quality of Life Impact of Refractive Correction (QIRC) instrument is demonstrably superior to other instruments in terms of validity and reliability, so is the ideal outcome measure for laser refractive surgery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ADVS:
-
Activities of Daily Vision Scale
- ICF:
-
International Classification of Functioning, Disability and Health
- LASEK:
-
Laser assisted sub-epithelial keratectomy
- LASIK:
-
Laser in situ keratomileusis
- NEI-RQL:
-
The National Eye Institute Refractive Quality of Life questionnaire
- PRK:
- PRO:
-
Patient reported outcome
- QIRC:
-
Quality of Life Impact of Refractive Correction questionnaire
- QOL:
-
Quality of Life
- RK:
-
Refractive keratectomy
- RSVP:
-
The Refractive Status Vision Profile
- WHO:
-
World Health Organization
References
Bailey MD, Mitchell GL, Dhaliwal DK, Boxer Wachler BS, Zadnik K. (2003). Ophthalmology. 110: 1371–1378.
Ben-Sira A, Loewenstein A, Lipshitz I, Levanon D, Lazar M. (1997). J Refract Surg. 13: 129–134.
Berry S, Mangione CM, Lindblad AS, McDonnell PJ. (2003). Ophthalmology. 110: 2285–2291.
Brunette I, Gresset J, Boivin JF, Pop M, Thompson P, Lafond GP, Makni H. (2000). Ophthalmology. 107: 1790–1796.
Charman WN. (1989). Ophthalmic Physiol Opt. 9: 424–430.
Chen CY, Keeffe JE, Garoufalis P, Islam FM, Dirani M, Couper TA, Taylor HR, Baird PN. (2007). J Refract Surg. 23: 752–759.
Dandona L, Dandona R. (2006). BMC Med. 4: 6.
de Boer MR, Moll AC, de Vet HC, Terwee CB, Volker-Dieben HJ, van Rens GH. (2004). Ophthalmic Physiol Opt. 24: 257–273.
Downing SM, Haladyna TM. (2004). Med Educ. 38: 327–333.
Garamendi E, Pesudovs K, Elliott DB. (2005). J Cataract Refract Surg. 31: 1537–1543.
Garamendi E, Pesudovs K, Stevens MJ, Elliott DB. (2006). Vision Res. 46: 1375–1383.
Hays RD, Mangione CM, Ellwein L, Lindblad AS, Spritzer KL, McDonnell PJ. (2003). Ophthalmology. 110: 2292–2301.
Kempen JH, Mitchell P, Lee KE, Tielsch JM, Broman AT, Taylor HR, Ikram MK, Congdon NG, O’Colmain BJ. (2004). Arch Ophthalmol. 122: 495–505.
La Grow S. (2007). Optom Vis Sci. 84: 785–788.
Lamoureux EL, Pallant JF, Pesudovs K, Hassell JB, Keeffe JE. (2006). Invest Ophthalmol Vis Sci. 47: 4732–4741.
Lee J, Park K, Cho W, Kim JY, Kang HY. (2005). J Refract Surg. 21: 59–71.
Likert RA. (1932). Arch Psychol. 140: 1–55.
Massof RW. (2005). Ophthalmic Epidemiol. 12: 103–124.
Massof RW. (2007). Optom Vis Sci. 84: 689–704.
Massof RW, Fletcher DC. (2001). Vision Res. 41: 397–413.
McDonnell PJ, Lee P, Spritzer K, Lindblad AS, Hays RD. (2003a). Arch Ophthalmol. 121: 1577–1581.
McDonnell PJ, Mangione C, Lee P, Lindblad AS, Spritzer KL, Berry S, Hays RD. (2003b). Ophthalmology. 110: 2302–2309.
McGhee CN, Craig JP, Sachdev N, Weed KH, Brown AD. (2000). J Cataract Refract Surg. 26: 497–509.
Nichols JJ, Mitchell GL, Saracino M, Zadnik K. (2003). Arch Ophthalmol. 121: 1289–1296.
Nichols JJ, Mitchell GL, Zadnik K. (2001). Ophthalmology. 108: 1160–1166.
Nichols JJ, Twa MD, Mitchell GL. (2005). J Cataract Refract Surg. 31: 2313–2318.
Norquist JM, Fitzpatrick R, Dawson J, Jenkinson C. (2004). Med Care. 42: I25–136.
Pesudovs K. (2006). BMC Ophthalmol. 6: 25.
Pesudovs K, Burr JM, Harley C, Elliott DB. (2007). Optom Vis Sci. 84: 663–674.
Pesudovs K, Garamendi E, Elliott DB. (2004). Optom Vis Sci. 81: 769–777.
Pesudovs K, Garamendi E, Elliott DB. (2006). J Refract Surg. 22: 19–27.
Pesudovs K, Garamendi E, Keeves JP, Elliott DB. (2003). Invest Ophthalmol Vis Sci. 44: 2892–2899.
Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J. (2006). Arch Ophthalmol. 124: 1754–1760.
Rose K, Harper R, Tromans C, Waterman C, Goldberg D, Haggerty C, Tullo A. (2000). Br J Ophthalmol. 84: 1031–1034.
Schein OD. (2000). Trans Am Ophthalmol Soc. 98: 439–469.
Schein OD, Vitale S, Cassard SD, Steinberg EP. (2001). J Cataract Refract Surg. 27: 665–673.
Schmidt GW, Yoon M, McGwin G, Lee PP, McLeod SD. (2007). Arch Ophthalmol. 125: 1037–1042.
Spaeth G, Walt J, Keener J. (2006). Am J Ophthalmol. 141: S3–S14.
Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, Legro MW, Diener-West M, Bass EB, Damiano AM, Steinwachs DM, Sommer A. (1994). Arch Ophthalmol. 112: 630–638.
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. (2007). J Clin Epidemiol. 60: 34–42.
Uusitalo RJ, Brans T, Pessi T, Tarkkanen A. (1999). J Cataract Refract Surg. 25: 989–994.
Valderas JM, Alonso J, Prieto L, Espallargues M, Castells X. (2004). Qual Life Res. 13: 35–44.
Vision Watch. (2003). Vision Correction Market Review. Jobson Publishing, New York.
Vitale S, Schein OD, Meinert CL, Steinberg EP. (2000). Ophthalmology. 107: 1529–1539.
Vitale S, Schein OD, Steinberg EP, Ware JE, Jr. (1997). Invest Ophthalmol Vis Sci. 38: S841.
Waring GO, 3rd. (2000). J Refract Surg. 16: 459–466.
Weisinger HS. (2006). J Refract Surg. 22: 14–15.
Wong TY, Foster PJ, Hee J, Ng TP, Tielsch JM, Chew SJ, Johnson GJ, Seah SK. (2000). Invest Ophthalmol Vis Sci. 41: 2486–2494.
Wong TY, Foster PJ, Johnson GJ, Seah SK. (2003). Invest Ophthalmol Vis Sci. 44: 1479–1485.
World Health Organization. (2001). The International Classification of Functioning, Disability and Health (ICF). World Health Organization, Geneva.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Pesudovs, K., Elliott, D.B. (2010). Quality of Life After Laser Surgery for Eye Disorders. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_139
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_139
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine